methotrexate has been researched along with Bright Disease in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (32.26) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 16 (51.61) | 29.6817 |
| 2010's | 2 (6.45) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Funada, M; Miyamoto, T; Nawata, A; Nawata, M; Saito, K; Tanaka, Y | 1 |
| Andres-Hernando, A; Cara-Fuentes, G; Garcia, GE; Johnson, RJ; Lanaspa, M; Leamon, CP; Lu, YJ; Miyazaki, M; Miyazaki-Anzai, S; Roncal-Jiménez, CA; Truong, LD | 1 |
| Balendran, K; Lanerolle, RD; Senarathne, LDSU | 1 |
| Bramsiepe, I; Danz, B; Fiedler, E; Heine, R; Holzhausen, HJ; Marsch, WC; Taube, KM | 1 |
| Aono, H; Ishihara, K; Katsuta, O; Takai, M; Tsuji, F; Yoshimi, M | 1 |
| Usui, J; Yamagata, K | 1 |
| Hirayama, K; Kobayashi, M; Koyama, A; Yamagata, K | 1 |
| Abramson, L; Arkachaisri, T; Benseler, S; Cabral, DA; Campillo, S; Chira, P; Dewitt, EM; Eberhard, A; Hashkes, PJ; Hersh, AO; Higgins, G; Huber, AM; Kim, S; Kingsbury, DJ; Klein-Gitelman, M; Levy, DM; Li, SC; Lovell, DJ; Mason, T; McCurdy, D; Muscal, E; Nassi, L; O'Neil, KM; Reiff, A; Schikler, K; Singer, NG; Stevens, A; Uribe, AG; Wahezi, D; Woodward, A; Zeft, AS | 1 |
| Brunet, P; Burtey, S; Dussol, B; Seck, SM | 1 |
| De Groot, K; Fink, CO; Gross, WL; Herlyn, K; Reinhold-Keller, E | 1 |
| Espinoza, LR | 2 |
| Araghi, P; Bianchi, G; Ciabattoni, M; Icardi, A; Lazzarini, P; Romano, U | 1 |
| Duman, M; Düzgün, N; Ensari, A; Güllü, S; Gürsoy, A; Kumbasar, OO; Morris, Y | 1 |
| Guillevin, L; Guilpain, P; Pagnoux, C | 1 |
| de Groot, K; Gross, WL; Hellmich, B; Iking-Konert, C; Manger, K; Metzler, C; Miehle, N; Reinhold-Keller, E | 1 |
| Akikusa, JD; Harvey, EA; Hebert, D; Laxer, RM; Schneider, R; Silverman, ED; Thorner, PS | 1 |
| Curi, PR; de Almeida, DB | 1 |
| Keusch, G | 1 |
| Heidbreder, E; Heidland, A | 1 |
| Bruno, M; Cosseddu, D; Linari, F; Manganaro, M; Pellerito, R; Ravarino, N; Torchio, B; Urbano, D | 1 |
| Langford, CA; Sneller, MC; Talar-Williams, C | 1 |
| Langford, CA | 1 |
| Asanuma, Y; Kato, M; Kawai, S; Nagai, K; Sugiura, H | 1 |
| Goubeaud, G; Schütterle, G | 1 |
| Baethke, R; Kampf, D | 1 |
| Wojnarowski, M; Wyszyńska, T | 1 |
| Betow, C; Rafii, MR | 1 |
| Fogel, M; Lewis, M; Segel, D; Shadduck, RK; Stolzer, BL; Winkelstein, A | 1 |
| Wilmanns, W | 1 |
| Asamer, H; Dittrich, M | 1 |
6 review(s) available for methotrexate and Bright Disease
| Article | Year |
|---|---|
[Treatment of rapidly progressive glomerulonephritis].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Blood Component Removal; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Plasma Exchange; Pulse Therapy, Drug | 2009 |
[Kidney involvement in rheumatoid arthritis].
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Autopsy; Biopsy; Cyclosporine; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Methotrexate; Nephritis, Interstitial; Penicillamine; Time Factors | 2003 |
[Microscopic polyangiitis].
Topics: Adrenal Cortex Hormones; Age Factors; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biological Therapy; Clinical Trials as Topic; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Infant, Newborn; Lung Diseases; Male; Methotrexate; Middle Aged; Plasma Exchange; Polyarteritis Nodosa; Prognosis; Recurrence; Remission Induction; Skin Diseases; Time Factors; Vasculitis | 2007 |
[Renal damage in rheumatoid arthritis].
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclosporine; Female; Glomerulonephritis; Gold; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Penicillamine; Vasculitis | 1994 |
[Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
Topics: Adrenal Cortex Hormones; Antibodies, Antinuclear; Azathioprine; Beta-Globulins; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Germany, West; Glomerulonephritis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Nephritis; Recurrence | 1974 |
[Indications for immunosuppressive treatment in kidney diseases of children].
Topics: Alkylating Agents; Anti-Bacterial Agents; Antimetabolites; Antineoplastic Agents; Azathioprine; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Glomerulonephritis; Humans; Immunosuppressive Agents; Mechlorethamine; Mercaptopurine; Methotrexate | 1969 |
3 trial(s) available for methotrexate and Bright Disease
| Article | Year |
|---|---|
High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Child; Drug Therapy, Combination; Female; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction | 2002 |
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Topics: Administration, Oral; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; C-Reactive Protein; Cyclophosphamide; Drug Administration Schedule; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Hemoptysis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukopenia; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome | 2007 |
Renal outcome in Wegener's granulomatosis.
Topics: Biopsy, Needle; Creatinine; Drug Therapy, Combination; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Kidney Function Tests; Male; Methotrexate; Prednisone; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
22 other study(ies) available for methotrexate and Bright Disease
| Article | Year |
|---|---|
Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.
Topics: Adult; Arthritis, Rheumatoid; Autoantibodies; Certolizumab Pegol; Female; Glomerulonephritis; Humans; Kidney; Methotrexate; Peroxidase; Rituximab; Tumor Necrosis Factor Inhibitors | 2021 |
A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats.
Topics: Aminopterin; Animals; Fibrosis; Folate Receptor 2; Folic Acid; Glomerulonephritis; Inflammation; Macrophages; Methotrexate; Rats | 2021 |
Crescentic glomerular nephritis associated with rheumatoid arthritis: a case report.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Edema; Female; Glomerulonephritis; Humans; Kidney; Methotrexate; Middle Aged; Proteinuria | 2017 |
[Primary cutaneous manifestation of Wegener's granulomatosis].
Topics: Antibodies, Antineutrophil Cytoplasmic; Biopsy; Drug Therapy, Combination; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Leg Dermatoses; Leukocyte Count; Male; Methotrexate; Middle Aged; Myeloblastin; Necrosis; Prednisolone; Skin; Skin Diseases, Vascular | 2008 |
Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Cytokine Receptor gp130; Genetic Predisposition to Disease; Glomerulonephritis; Hyperplasia; Joints; Lymphoid Tissue; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Organ Size; Point Mutation; Species Specificity; Spleen; Stifle | 2009 |
[Present status and future perspective of RPGN in Japan].
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Component Removal; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunosuppressive Agents; Japan; Methotrexate; Multicenter Studies as Topic; Prognosis; Recurrence; Severity of Illness Index; Surveys and Questionnaires | 2009 |
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.
Topics: Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Churg-Strauss Syndrome; Cohort Studies; Cyclophosphamide; Diagnosis, Differential; Europe; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Microscopic Polyangiitis; Pilot Projects; Reference Standards; Sensitivity and Specificity; Societies, Medical; United States; Vasculitis | 2009 |
Clinical features and outcomes of ANCA-associated renal vasculitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Churg-Strauss Syndrome; Creatinine; Cyclophosphamide; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Male; Methotrexate; Microscopic Polyangiitis; Middle Aged; Plasmapheresis; Recurrence; Remission Induction; Renal Dialysis; Retrospective Studies | 2012 |
Renal relapse in Wegener's granulomatosis.
Topics: Antirheumatic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Methotrexate; Middle Aged; Remission Induction; Secondary Prevention | 2003 |
Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener's granulomatosis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Diabetes Insipidus; Diagnosis, Differential; Drug Therapy, Combination; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Pituitary Gland, Posterior; Prednisone; Solitary Pulmonary Nodule; Treatment Outcome | 2005 |
Clinical features and outcome of pediatric Wegener's granulomatosis.
Topics: Adolescent; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Lung Diseases; Male; Methotrexate; Prednisone; Retrospective Studies; Treatment Outcome | 2007 |
Treatment of rat nephrotoxic nephritis. Use of 5-fluorouracil or methotrexate-5-fluorouracil association.
Topics: Animals; Drug Therapy, Combination; Fluorescent Antibody Technique; Fluorouracil; Glomerulonephritis; Kidney; Kidney Function Tests; Male; Methotrexate; Rats; Rats, Inbred Strains | 1984 |
[Drug-induced kidney disorders].
Topics: Aminoglycosides; Anti-Bacterial Agents; Glomerulonephritis; Humans; Ischemia; Kidney; Kidney Diseases; Methotrexate; Nephritis, Interstitial | 1982 |
[Toxic nephropathies (author's transl)].
Topics: Analgesics; Drug Hypersensitivity; Ethylene Glycols; Glomerulonephritis; Humans; Hypercalcemia; Kidney Concentrating Ability; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubular Necrosis, Acute; Methicillin; Methotrexate; Nephritis, Interstitial; Oxalates | 1980 |
Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.
Topics: Adult; Antirheumatic Agents; Cohort Studies; Creatinine; Female; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Time Factors; Treatment Outcome | 2000 |
Wegener granulomatosis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Methotrexate; Respiratory System | 2001 |
Weekly pulse therapy of methotrexate improves survival compared with its daily administration in MRL/lpr mice.
Topics: Animals; Antirheumatic Agents; Autoantibodies; Autoimmunity; Blood Cell Count; Body Weight; Glomerulonephritis; Kidney Function Tests; Lupus Erythematosus, Systemic; Lymphatic Diseases; Male; Methotrexate; Mice; Mice, Inbred MRL lpr; Proteinuria; Radiography; Survival Analysis; Urea | 2002 |
[Possibilities and limitations of immunosuppressive therapy for glomerulonephritis].
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Chlorambucil; Chronic Disease; Cyclophosphamide; Dactinomycin; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Glomerulus; Mercaptopurine; Methotrexate | 1977 |
[Wegener's granulomatosis. Contribution to the diagnosis, therapy and course].
Topics: Aged; Chlorambucil; Cyclophosphamide; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Inflammation; Male; Methotrexate; Middle Aged; Prednisone; Vascular Diseases | 1974 |
Immunosuppressive therapy.
Topics: Anemia, Hemolytic, Autoimmune; Antigen-Antibody Reactions; Arthritis, Rheumatoid; Azathioprine; Crohn Disease; Cyclophosphamide; Female; Glomerulonephritis; Glucocorticoids; Hepatitis; Humans; Immunity; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Purpura, Thrombocytopenic | 1973 |
[Dihydrofolate reductase and thymidine kinase in the bone marrow under the influence of folic acid antagonists].
Topics: Adult; Amyloidosis; Bone Marrow; Bone Marrow Cells; Chronic Disease; Clinical Enzyme Tests; DNA; Erythropoiesis; Female; Folic Acid Antagonists; Glomerulonephritis; Humans; In Vitro Techniques; Lupus Erythematosus, Systemic; Male; Methotrexate; Suicide; Tetrahydrofolate Dehydrogenase; Thymidine Kinase | 1967 |
QImmunosuppressive therapy of glomerulonephritis.
Topics: Azathioprine; Biopsy; Glomerulonephritis; Humans; Immunosuppressive Agents; Methotrexate; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1970 |